Loading...
XSTO
S2M
Market cap483kUSD
Jul 10, Last price  
0.01SEK
1D
0.00%
1Q
-40.91%
IPO
-99.98%
Name

S2Medical AB (publ)

Chart & Performance

D1W1MN
XSTO:S2M chart
P/E
P/S
0.33
EPS
Div Yield, %
Shrs. gr., 5y
79.43%
Rev. gr., 5y
-10.93%
Revenues
14m
-3.66%
1,534,524340,000844,0001,495,5823,098,45925,615,6127,699,7864,670,2026,971,34614,906,00014,361,000
Net income
-10m
L
2,796-1,195,000-5,377,000-10,730,770-18,435,731-15,082,085-20,079,249-29,456,402-22,707,4575,771,000-10,092,000
CFO
675k
-86.58%
0-3,031,000-5,846,000-12,753,554-17,103,985-12,749,160-19,665,185-28,131,269-16,519,8845,030,836675,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

S2Medical AB (publ) focuses on the development, production, and commercialization of advanced wound care solutions, specifically targeting burns and chronic wounds. Their product range features INSTAQRETT, a sterile, disposable tool for mechanical debridement; EPIPROTECT SafeStop, designed to control bleeding; and Instagraft, a single-use medical device for treating complex and prolonged wounds. The company also supplies EPIPROTECT tissue replacement products and INSTABIND-branded bandages, which are known for being washable, waterproof, and self-adhesive. Furthermore, S2Medical distributes Silverlon dressings, which facilitate the delivery of silver ions to the wound. In addition to its product offerings, the company operates specialized wound healing centers known as S2Clinic. Founded in 2013, S2Medical is headquartered in Linköping, Sweden.
IPO date
Nov 28, 2018
Employees
20
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT